Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up von Malorni, L., Shetty, P. B., De Angelis, C., Hilsenbeck, S., Rimawi, M. F., Elledge, R., Osborne, C. K., De Placido, S., Arpino, G.

Volltext

Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2–Positive Breast Cancer von Shou, Jiang, Massarweh, Suleiman, Osborne, C. Kent, Wakeling, Alan E., Ali, Simale, Weiss, Heidi, Schiff, Rachel

Volltext

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer von Osborne, C. Kent, Bardou, Valerie, Hopp, Torsten A., Chamness, Gary C., Hilsenbeck, Susan G., Fuqua, Suzanne A. W., Wong, Jiemin, Allred, D. Craig, Clark, Gary M., Schiff, Rachel

Volltext

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study von Hertz, D. L., Kidwell, K. M., Hilsenbeck, S. G., Oesterreich, S., Osborne, C. K., Philips, S., Chenault, C., Hartmaier, R. J., Skaar, T. C., Sikora, M. J., Rae, J. M.

Volltext

Tamoxifen in the Treatment of Breast Cancer von Osborne, C. Kent

Volltext

Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior En... von OSBORNE, C. K, PIPPEN, J, WEBSTER, A, MORRIS, C, ELLEDGE, R, BUZDAR, A, JONES, S. E, PARKER, L. M, ELLIS, M, COME, S, GERTLER, S. Z, MAY, J. T, BURTON, G, DIMERY, I

Volltext

Systemic mirnas as potential biomarkers for malignancy von Healy, N.A., Heneghan, H.M., Miller, N., Osborne, C.K., Schiff, R., Kerin, M.J.

Volltext

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action von Osborne, C K, Wakeling, A, Nicholson, R I

Volltext

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer von HARVEY, J. M, CLARK, G. M, OSBORNE, C. K, ALLRED, D. C

Volltext

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 von Curigliano, G, Burstein, H.J., Winer, E.P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M.M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S.Y., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D.F., Huang, C.-S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K.C., Pagani, O., Partridge, A.H., Pritchard, K., Ro, J., Rutgers, E.J.T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T.J., Xu, B.

Volltext

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients von Rodriguez, A. A, Makris, A, Wu, M. F, Rimawi, M, Froehlich, A, Dave, B, Hilsenbeck, S. G, Chamness, G. C, Lewis, M. T, Dobrolecki, L. E, Jain, D, Sahoo, S, Osborne, C. K, Chang, J. C

Volltext

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy von Li, Xiaoxian, Lewis, Michael T., Huang, Jian, Gutierrez, Carolina, Osborne, C. Kent, Wu, Meng-Fen, Hilsenbeck, Susan G., Pavlick, Anne, Zhang, Xiaomei, Chamness, Gary C., Wong, Helen, Rosen, Jeffrey, Chang, Jenny C.

Volltext

Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast Cancer von CHANG, J, POWLES, T. J, ALLRED, D. C, ASHLEY, S. E, CLARK, G. M, MAKRIS, A, ASSERSOHN, L, GREGORY, R. K, OSBORNE, C. K, DOWSETT, M

Volltext

Selective Estrogen Receptor Modulators: Structure, Function, and Clinical Use von OSBORNE, C. K, HONG ZHAO, FUQUA, S. A. W

Volltext

Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women von LaCroix, Andrea Z., Powles, Trevor, Osborne, C. Kent, Wolter, Kevin, Thompson, John R., Thompson, David D., Allred, D. Craig, Armstrong, Róisín, Cummings, Steve R., Eastell, Richard, Ensrud, Kristine E., Goss, Paul, Lee, Andrew, Neven, Patrick, Reid, David M., Curto, Madelyn, Vukicevic, Slobodan

Volltext

Significance of Axillary Lymph Node Metastasis in Primary Breast Cancer von JATOI, I, HILSENBECK, S. G, CLARK, G. M, OSBORNE, C. K

Volltext

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand‐binding assay compared with ER, PgR and pS2, by immuno‐histochemistry in predicting response to tamoxifen in metas... von Elledge, Richard M., Green, Stephanie, Pugh, Reginald, Allred, D. Craig, Clark, Gary M., Hill, Julian, Ravdin, Peter, Martino, Silvana, Osborne, C. Kent

Volltext

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study von ELLEDGE, R. M, GREEN, S, OSBORNE, C. K, CIOCCA, D, PUGH, R, ALLRED, D. C, CLARK, G. M, HILL, J, RAVDIN, P, O'SULLIVAN, J, MARTINO, S

Volltext

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer von Veeraraghavan, J., De Angelis, C., Mao, R., Wang, T., Herrera, S., Pavlick, A.C., Contreras, A., Nuciforo, P., Mayer, I.A., Forero, A., Nanda, R., Goetz, M.P., Chang, J.C., Wolff, A.C., Krop, I.E., Fuqua, S.A.W., Prat, A., Hilsenbeck, S.G., Weigelt, B., Reis-Filho, J.S., Gutierrez, C., Osborne, C.K., Rimawi, M.F., Schiff, R.

Volltext

Fulvestrant (Faslodex™) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: c... von Mauriac, L., Pippen, J.E., Quaresma Albano, J., Gertler, S.Z., Osborne, C.K.

Volltext